Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma

S. Krueger, S. Pauls, F. Mottaghy, A. Buck, H. Schelzig, V. Hombach, S. Reske (Ulm, Germany)

Source: Annual Congress 2007 - Pleural malignancy
Session: Pleural malignancy
Session type: Oral Presentation
Number: 4455
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Krueger, S. Pauls, F. Mottaghy, A. Buck, H. Schelzig, V. Hombach, S. Reske (Ulm, Germany). Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma. Eur Respir J 2007; 30: Suppl. 51, 4455

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of pleural disease with FDG-PET imaging
Source: Annual Congress 2003 - Early lung cancer diagnosis
Year: 2003


Integrated CT-PET is a valuable tool for staging malignant pleural mesothelioma
Source: ISSN=ISSN 1810-6838, ISBN=, page=173
Year: 2005

Relevance of FDG-PET-CT scan for the evaluation of local pleural invasion assessed by thoracoscopy in malignant pleural mesothelioma
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


The diagnostic value of 18F-FDG PET/CT scanning for discriminating malignant from non-malignant causes in unilateral pleural effusions
Source: International Congress 2018 – Imaging of various diseases with different imaging modalities
Year: 2018

Use of integrated FDG PET/CT imaging in pulmonary cacinoid tumors
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006

Imaging of malignant pleural mesothelioma with fluordeoxyglucose positron emission tomography (FDG-PET)
Source: Eur Respir J 2001; 18: Suppl. 33, 396s
Year: 2001

Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


The usefulness of dynamic CT and 18F-FDG PET to distinguish between benignancy and malignancy in solitary pulmonary nodule
Source: Eur Respir J 2007; 30: Suppl. 51, 532s
Year: 2007

PET predicts survival in malignant pleural mesothelioma
Source: ISSN=ISSN 1810-6838, ISBN=, page=290
Year: 2007

Cytology, chest computed and positron emission tomography correlations in lung cancer malignant pleural effusion.
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018

Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging?
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
Source: Eur Respir J 2007; 29: 995-1002
Year: 2007



Use of integrated FDG PET/CT imaging in sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 542s
Year: 2006

Endobronchial ultrasound guided biopsy (EBUS–TBNA) for staging of patients with lung cancer without mediastinal involvement at positron emission tomography-computed tomography (PET-CT)
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016


Analysis of the solitary pulmonary nodule after surgical resection in patients using 18F-FDG integrated PET-CT scan at preoperative work-up.
Source: International Congress 2018 – Thoracic surgery, pleural effusions and other general thoracic surgery
Year: 2018


Comparison of CT and PET in detection of lung metastases
Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging
Year: 2004


Assessment with STIR MR imaging and PET-CT for malignant or benign lesion in the mediastinal and hilar lymph nodes
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



Correlation between histological yield of intrathoracic nodal EBUS biopsy and SUVmax in 18F-FDG PET scan
Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies
Year: 2021


Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008


Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?
Source: Eur Respir J 2011; 37: 162-168
Year: 2011